DNA methylation and microRNA dysregulation in cancer
- PMID: 22902148
- PMCID: PMC5528344
- DOI: 10.1016/j.molonc.2012.07.007
DNA methylation and microRNA dysregulation in cancer
Abstract
DNA methylation plays a key role in the silencing of numerous cancer-related genes, thereby affecting a number of vital cellular processes, including the cell cycle checkpoint, apoptosis, signal transduction, cell adhesion and angiogenesis. Also widely altered in human malignancies is the expression of microRNAs (miRNAs), a class of small noncoding RNAs that act as posttranscriptional regulators of gene expression. Furthermore, emerging evidence now supports the idea that DNA methylation is crucially involved in the dysregulation of miRNAs in cancer. This is in part the result of technological advances that enable more comprehensive analysis of miRNA expression profiles and the epigenome in cancer cells, which has led to the identification of a number of epigenetically regulated miRNAs. As with protein-coding genes, it appears that miRNA genes involved in regulating cancer-related pathways are silenced in association with CpG island hypermethylation. In addition, methylation in CpG island shore regions and DNA hypomethylation also appear to contribute to miRNA dysregulation in cancer. Aberrant DNA methylation of miRNA genes is a potentially useful biomarker for detecting cancer and predicting its outcome. Moreover, re-expression of miRNAs and the replacement of tumor suppressive miRNAs using miRNA mimics or expression vectors could be effective approaches to cancer therapy.
Copyright © 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
Figures
References
-
- Agirre, X. , Vilas-Zornoza, A. , Jimenez-Velasco, A. , Martin-Subero, J.I. , Cordeu, L. , Garate, L. , San Jose-Eneriz, E. , Abizanda, G. , Rodriguez-Otero, P. , Fortes, P. , Rifon, J. , Bandres, E. , Calasanz, M.J. , Martin, V. , Heiniger, A. , Torres, A. , Siebert, R. , Roman-Gomez, J. , Prosper, F. , 2009. Epigenetic silencing of the tumor suppressor microRNA Hsa-miR-124a regulates CDK6 expression and confers a poor prognosis in acute lymphoblastic leukemia. Cancer Res. 69, 4443–4453. - PubMed
-
- Ando, T. , Yoshida, T. , Enomoto, S. , Asada, K. , Tatematsu, M. , Ichinose, M. , Sugiyama, T. , Ushijima, T. , 2009. DNA methylation of microRNA genes in gastric mucosae of gastric cancer patients: its possible involvement in the formation of epigenetic field defect. Int. J. Cancer. 124, 2367–2374. - PubMed
-
- Bandres, E. , Agirre, X. , Bitarte, N. , Ramirez, N. , Zarate, R. , Roman-Gomez, J. , Prosper, F. , Garcia-Foncillas, J. , 2009. Epigenetic regulation of microRNA expression in colorectal cancer. Int. J. Cancer. 125, 2737–2743. - PubMed
-
- Bommer, G.T. , Gerin, I. , Feng, Y. , Kaczorowski, A.J. , Kuick, R. , Love, R.E. , Zhai, Y. , Giordano, T.J. , Qin, Z.S. , Moore, B.B. , MacDougald, O.A. , Cho, K.R. , Fearon, E.R. , 2007. p53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr. Biol. 17, 1298–1307. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
